These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3478081)

  • 1. The value of CA 125 serum assay in the management of ovarian cancer. Commentary.
    Jacobs I; Oram D
    Br J Obstet Gynaecol; 1987 Aug; 94(8):819-21. PubMed ID: 3478081
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian cancer screening: new trial tries new twists.
    McNeil C
    J Natl Cancer Inst; 1995 Sep; 87(17):1283-5. PubMed ID: 7658479
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.
    Jacobs IJ; Oram DH; Bast RC
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):396-9. PubMed ID: 1495694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening in ovarian cancer.
    Creasman WT; DiSaia PJ
    Am J Obstet Gynecol; 1991 Jul; 165(1):7-10. PubMed ID: 1853918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined evaluation of serum CA 125 and CAM 29 in patients with epithelial ovarian cancer.
    Ferdeghini M; Gadducci A; Prontera C; Malagnino G; Annicchiarico C; Prato B; Bianchi R; Fioretti P
    Tumour Biol; 1992; 13(5-6):287-93. PubMed ID: 1290026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for ovarian cancer. Still controversial, but encouraging.
    Wald N; Parkes C
    BMJ; 1993 Jun; 306(6893):1684. PubMed ID: 8324444
    [No Abstract]   [Full Text] [Related]  

  • 7. Ovarian cancer.
    van Nagell JR
    Gynecol Oncol; 1991 Nov; 43(2):89-91. PubMed ID: 1743563
    [No Abstract]   [Full Text] [Related]  

  • 8. Ovarian cancer screening.
    van Nagell JR
    Cancer; 1991 Aug; 68(4):679-80. PubMed ID: 1855166
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for ovarian cancer.
    Powell MA
    J Am Acad Nurse Pract; 1992; 4(1):36-7. PubMed ID: 1605991
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for ovarian cancer.
    Webb MJ
    BMJ; 1993 Apr; 306(6884):1015-6. PubMed ID: 8369042
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for ovarian cancer. Other malignancies cloud the issue.
    Clements D
    BMJ; 1993 Jun; 306(6893):1685. PubMed ID: 8324446
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cancer of the ovary. Comparative value of serum CA-125, immunochemistry and biological tests of inflammation].
    Gosselin P; Cazin JL; Dehaut JP; Delobelle A; Granier AM; Sulman C; Demaille MC
    Rev Fr Gynecol Obstet; 1987 Jan; 82(1):1-5. PubMed ID: 3554460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal approach to screening for ovarian cancer.
    Jacobs I; Stabile I; Bridges J; Kemsley P; Reynolds C; Grudzinskas J; Oram D
    Lancet; 1988 Feb; 1(8580):268-71. PubMed ID: 2893084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of tumor-associated mucin-type glycoprotein CA 54/61 in ovarian cancers: comparison with CA 125.
    Suzuki M; Sekiguchi I; Tamada T
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):422-7. PubMed ID: 2381620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA-125 as a screening test for ovarian cancer.
    Gocze PM; Freeman DA
    JAMA; 1993 Jun 23-30; 269(24):3106-7. PubMed ID: 8505808
    [No Abstract]   [Full Text] [Related]  

  • 16. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
    Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
    Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing serum CA 125 levels in normal women.
    Grover S; Quinn MA; Weideman P; Koh H
    Obstet Gynecol; 1992 Apr; 79(4):511-4. PubMed ID: 1553167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of CA 125 serum assay in the management of ovarian cancer.
    Lambert J
    Br J Obstet Gynaecol; 1987 Mar; 94(3):193-5. PubMed ID: 3471272
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for ovarian cancer by CA-125 measurement.
    Jacobs I
    Lancet; 1988 Apr; 1(8590):889. PubMed ID: 2895400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.